Abstract
Brain injury constitutes a disabling health condition of several etiologies. One of the major causes of brain injury is hypoxia-ischemia. Until recently, pharmacological treatments were solely focused on neurons. In the last decades, glial cells started to be considered as alternative targets for neuroprotection. Novel treatments for hypoxia-ischemia intend to modulate reactive forms of glial cells, and/or potentiate their recovery response. In this review, we summarize these neuroprotective strategies in hypoxia-ischemia and discuss their mechanisms of action.
Cite
CITATION STYLE
Mucci, S., Herrera, M. I., Barreto, G. E., Kolliker-Frers, R., & Capani, F. (2017). Neuroprotection in Hypoxic-Ischemic Brain Injury Targeting Glial Cells. Current Pharmaceutical Design, 23(26). https://doi.org/10.2174/1381612823666170727145422
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.